Source: Virtual Congress 2020 – COPD phenotypes
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Conde (Vila Real, Portugal), B. Conde (Vila Real, Portugal), C. Parra (Vila Real, Portugal), A. Vale (Vila Real, Portugal), A. Fernandes (Vila Real, Portugal). Characterization of a patient population phenotyped for alpha-1-antitrypsin. 2434

Member's Comments

No comment yet.

Related content which might interest you: Characterization of a population of alpha1-antitrypsin deficient (A1ATD) patients Source: Annual Congress 2008 - COPD Year: 2008 Molecular characterization of novel PiS-like alleles identified in Spanish patients with Alpha-1 antitrypsin deficiency Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 Pilot study for detection of alpha-1 antitrypsin deficiency in a targeted Argentinean population Source: Eur Respir J 2005; 26: Suppl. 49, 59s Year: 2005 Identification of individuals with alpha-1-antitrypsin deficiency by a targeted screening program Source: Annual Congress 2007 - Lung function and therapy in obstructive lung diseases Year: 2007 Prevalence and phenotype of subjects carrying rare variants in Argentina for alpha1-antitrypsin deficiency Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases Year: 2017 Risk of cancer in individuals with severe alpha-1-antitrypsin deficiency (PiZZ) compared with the Swedish general population Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement? Year: 2020 Trends in diagnosis and clinical presentation of alpha-1 antitrypsin deficiency within an Irish population Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Rare alpha-1 antitrypsin mutations in the Irish population Source: Annual Congress 2012 - COPD inflammation and genes Year: 2012 Rare alpha-1 antitrypsin mutations in the Irish population Source: Annual Congress 2011 - Genetic and environmental risk factors for respiratory diseases Year: 2011 Plasma levels of soluble CD14 in asymptomatic PiZZ and PiSZ subjects. Follow-up of the Swedish neonatal screening cohort Source: Annual Congress 2007 - Unravelling molecular mysteries of COPD Year: 2007 Screening of alpha-1 antitrypsin deficiency in a blood donors cohort of the North-Italian area Source: International Congress 2015 – Prevalence of respiratory disease Year: 2015 Alpha1-antitrypsin deficiency-related PI*Z and PI*S alleles in a random sample of Polish population Source: Eur Respir J 2006; 28: Suppl. 50, 453s Year: 2006 Differences of disease phenotypes in individuals with alpha-1-antitrypsin deficiency with genotypes PiZZ and PiSZ - Analysis from the German registry Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Screening for alpha-1 antitrypsin deficiency in Polish lung or liver disease patients Source: Annual Congress 2011 - Lung development and neoplasia Year: 2011 SERPINA1 gene variants in subjects from a general population with reduced alpha1-antitrypsin level Source: Annual Congress 2008 - COPD Year: 2008 Characteristics of zz alpha-1 antitrypsin deficiency patients on the Irish national registry Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Characterisation of alpha-1 antitrypsin protein expression and secretion in natural killer cells from healthy volunteers and alpha-1 antitrypsin deficiency patients Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021 Clinical considerations in individuals with a1-antitrypsin PI*SZ genotype Source: Eur Respir J, 55 (6) 1902410; 10.1183/13993003.02410-2019 Year: 2020 Influence of two novel mutations in surfactant protein-c on lung function and disease: resequencing of 760 individuals followed by genotyping of 48,000 individuals from the general population Source: Annual Congress 2009 - Risk factors for COPD Year: 2009 COPD in individuals with the PiMZ alpha-1 antitrypsin genotype Source: Eur Respir Rev, 26 (146) 170068; 10.1183/16000617.0068-2017 Year: 2017